Supersulphides provide airway protection in viral and chronic lung diseases

超硫化物可在病毒性和慢性肺部疾病中提供呼吸道保护。

阅读:10
作者:Tetsuro Matsunaga #,Hirohito Sano #,Katsuya Takita #,Masanobu Morita #,Shun Yamanaka,Tomohiro Ichikawa,Tadahisa Numakura,Tomoaki Ida,Minkyung Jung,Seiryo Ogata,Sunghyeon Yoon,Naoya Fujino,Yorihiko Kyogoku,Yusaku Sasaki,Akira Koarai,Tsutomu Tamada,Atsuhiko Toyama,Takakazu Nakabayashi,Lisa Kageyama,Shigeru Kyuwa,Kenji Inaba,Satoshi Watanabe,Péter Nagy,Tomohiro Sawa,Hiroyuki Oshiumi,Masakazu Ichinose,Mitsuhiro Yamada,Hisatoshi Sugiura,Fan-Yan Wei,Hozumi Motohashi,Takaaki Akaike

Abstract

Supersulphides are inorganic and organic sulphides with sulphur catenation with diverse physiological functions. Their synthesis is mainly mediated by mitochondrial cysteinyl-tRNA synthetase (CARS2) that functions as a principal cysteine persulphide synthase (CPERS). Here, we identify protective functions of supersulphides in viral airway infections (influenza and COVID-19), in aged lungs and in chronic lung diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF). We develop a method for breath supersulphur-omics and demonstrate that levels of exhaled supersulphides increase in people with COVID-19 infection and in a hamster model of SARS-CoV-2 infection. Lung damage and subsequent lethality that result from oxidative stress and inflammation in mouse models of COPD, IPF, and ageing were mitigated by endogenous supersulphides production by CARS2/CPERS or exogenous administration of the supersulphide donor glutathione trisulphide. We revealed a protective role of supersulphides in airways with various viral or chronic insults and demonstrated the potential of targeting supersulphides in lung disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。